Security record · archived quarter
GPCR
Structure Therapeutics Inc. · Healthcare · Biotechnology
11Tracked holders
—Δ holders
14.51MShares held
$569.72MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 66 | 0 | 29.19M | $1.56B | +7 | −7 |
| Q1 2026 | 68 | -4 | 35.35M | $1.72B | +6 | −10 |
| Q4 2025 | 71 | 0 | 34.16M | $2.38B | +1 | −1 |
| Q3 2025 | 15 | 0 | 15.29M | $428.25M | +1 | −1 |
| Q2 2025 | 12 | 0 | 15.65M | $324.65M | — | — |
| Q1 2025 | 10 | +2 | 10.69M | $185.13M | +2 | — |
| Q4 2024 | 8 | -1 | 12.53M | $339.72M | — | −1 |
| Q3 2024 | 8 | -3 | 13.88M | $609.35M | — | −3 |
| Q2 2024 | 11 | — | 14.51M | $569.72M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 7.55M | — | $296.41M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 7.55M | — | $296.41M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 7.55M | — | $296.41M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 7.55M | — | $296.41M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 7.55M | — | $296.41M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 7.55M | — | $296.41M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.31M | — | $90.85M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.41M | — | $55.31M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 1.41M | — | $55.31M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 1.21M | — | $47.64M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 1.14M | — | $44.74M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 367.68K | — | $14.44M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Capital World Investors ✦ | 323.76K | — | $12.71M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 75.93K | — | $2.98M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 75.93K | — | $2.98M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passive) | 44.91K | — | $1.76M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Duquesne Family Office ✦ | 37.70K | — | $1.48M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 35.70K | — | $1.40M | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 118.22K shares, $5.19M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Aug 06
SC 13G/A — FMR LLC
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API